期刊文献+

血清YKL-40浓度与2型糖尿病大血管病变的相关性研究 被引量:8

Association between YKL-40 and type 2 diabetic microangiopathy
原文传递
导出
摘要 目的探讨血清几丁质酶-3样蛋白-1(YKL-40)与2型糖尿病大血管病变的关联。方法选择2型糖尿病患者420例,根据有无大血管病变分为两组,另选健康体检者210例作为对照。采用酶联免疫吸附法检测各组血清YKL-40水平,并检测糖化血红蛋白(Hb A1c)、空腹胰岛素(FINS)、空腹血糖(FPG)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)等。结果 2型糖尿病组YKL-40明显高于对照组,2型糖尿病合并大血管病变组明显高于单纯2型糖尿病组(P<0.05);2型糖尿病患者的YKL-40与腰臀比(WHR)、胰岛素抵抗指数(HOMR-IR)、FINS、Hb A1c、IL-6、TNF-α呈正相关(r值分别为0.466、0.423、0.375、0.492、0.578、0.635,均P<0.05)。结论 YKL-40与2型糖尿病大血管病变的发生、发展有着密切关系,血清YKL-40检测对2型糖尿病大血管病变的早期预测有重要意义。 Objective To study the association between chitinase-3-like-1 protein (YKL-40) in serum and type 2 diabetic microangiopathy.Methods A total of 420 type 2 diabetic patients were divided into two groups, with microangiopathy (group A), and without microangiopathy (group B). And, 210 healthy subjects were chosen as control group (group C). The levels of YKL-40 were detected by enzyme linked immunosorbent assay, and the levels of glycosylated hemoglobin (HbA1c), fasting insulin (FINS), fasting blood-glucose (FPG), triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterin (LDL-C), high density lipoprotein cholesterol (HDL-C), interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α) were detected, too.Results The levels of YKL-40 in group A and B were higher than that in group C (P〈0.05), and the level of YKL-40 in group A was higher than that in group B (P〈0.05). The YKL-40 level in serum of type 2 diabetic patients was positively correlated with waist hip rate (WHR), insulin resistance index (HOMR-IR), FINS, HbA1c, IL-6, and TNF-α (the values ofr were respectively 0.466, 0.423, 0.375, 0.492, 0.578, and 0.635,P〈0.05).Conclusion YKL-40 is closely associated with the beginning and development of type 2 diabetic microangiopathy, and the detection of YKL-40 in serum is significant for early prediction of type 2 diabetic microangiopathy.
出处 《中华临床医师杂志(电子版)》 CAS 2015年第17期56-60,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 糖尿病 2型 YKL-40 糖尿病大血管病变 Diabetes mellitus, type 2 YKL-40 Diabetic microangiopathy
  • 相关文献

参考文献21

  • 1Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and CancerEJ]. Dan Med Bull, 2006, 53(2): 172-209.
  • 2Schrijvers DM, De Meyer GR, Herman AG, et al. Phagoeytosis in atheroselerosis: molecular mechanisms and implications for plaque progression and stability[J]. Cardiovase Res, 2007, 73(3): 470-480.
  • 3Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis[J]. Inflamm Res, 2006, 55(6): 221-227.
  • 4Kueur M, Isman FK, Karadag B, et al. Serum YKI0 levels in patients with coronary artery disease[J]. Coron Artery Dis, 2007, 18(5): 391-396.
  • 5Rathcke CN, Persson F, Tamow L, et al. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria[J]. Diabetes Care, 2009, 32(2): 323-328.
  • 6韩金玉,邵滢,王秋月.2型糖尿病患者血清YKL40水平与尿白蛋白的相关性[J].中华内分泌代谢杂志,2014,30(3):225-227. 被引量:7
  • 7Scshasai SR, Kaptogc S, Thompson A, ct al. Diabetes mellitus, fasting glucose, and risk of cause-specific death[J]. N Engl J Mcd, 2011,364(9): 829-841.
  • 8Johansen JS, Jenscn BV, Roslind A, et al. Serum YKL-40, a new prognostic biomarker in cancer patients?[J]. Cancer Epiderniol Biomarkers Prey, 2006, 15(9): 194-202.
  • 9Rathcke CN, Johanscn JS, Vcstergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance[J]. Inflamm Res, 2006, 55(2): 53-59.
  • 10Brix JM, H6Uefl F, Koppensteiner R, et al. YKL-40 in type 2 diabetic patients with different levels of albuminuria[j]. Eur J Clin Invest, 2011, 41(6): 589-596.

二级参考文献34

  • 1Persson F, Rathcke CN, Gall MA, et al. High YKL-40 levels predict mortality in patients with type 2 diabetes[J]. Diabetes Res Clin Pract, 2012,96:84-89.
  • 2Thomsen SB, Rathcke CN, Zerahn B, et al. Increased levels of the calcification marker Matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease[J]. Cardiovasc Diabetol, 2010,8:86.
  • 3Moresco RN, Sangoi MB, De Carvalho JA, et al. Diabetic nephropathy: traditional to proteomic markers[J]. Clin Chim Acta, 2013,421:17-30.
  • 4Kanasaki K, Taduri G, Koya D. Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis[J]. Front Endocrinol (Lausanne), 2013,4:7.
  • 5Ogawa D, Makino H. Pathogenesis of diabetic nephropathy: the role of inflammation[J]. Nihon Rinsho, 2012,70 Suppl 5:389-392.
  • 6Rathcke CN, Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes[J]. Cardiovasc Diabetol, 2009,8:61.
  • 7Ma WH, Wang XL, Du YM, et al. Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension[J]. BMC Cardiovasc Disord, 2012,12:35.
  • 8Kastrup J, Johansen JS, Winkel P, et al. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease[J]. Eur Heart J, 2009,30:1066-1072.
  • 9Nielsen AR, Erikstrup C, Johansen JS, et al. Plasma YKL-40: a BMI-independent marker of type 2 diabetes[J]. Diabetes, 2008,57:3078-3082.
  • 10Lee JH, Kim SS, Kim IJ, et al. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients[J]. J Diabetes Complications, 2012,26:308-312.

共引文献13

同被引文献63

  • 1韩俊霞,王秋萍,成兴波.血清CTRP12水平与2型糖尿病和肥胖的相关性研究[J].中国血液流变学杂志,2020(3):326-328. 被引量:5
  • 2Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and CancerEJ]. Dan Med Bull, 2006, 53(2): 172-209.
  • 3Schrijvers DM, De Meyer GR, Herman AG, et al. Phagoeytosis in atheroselerosis: molecular mechanisms and implications for plaque progression and stability[J]. Cardiovase Res, 2007, 73(3): 470-480.
  • 4Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis[J]. Inflamm Res, 2006, 55(6): 221-227.
  • 5Kueur M, Isman FK, Karadag B, et al. Serum YKI0 levels in patients with coronary artery disease[J]. Coron Artery Dis, 2007, 18(5): 391-396.
  • 6Rathcke CN, Persson F, Tamow L, et al. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria[J]. Diabetes Care, 2009, 32(2): 323-328.
  • 7Scshasai SR, Kaptogc S, Thompson A, ct al. Diabetes mellitus, fasting glucose, and risk of cause-specific death[J]. N Engl J Mcd, 2011,364(9): 829-841.
  • 8Johansen JS, Jenscn BV, Roslind A, et al. Serum YKL-40, a new prognostic biomarker in cancer patients?[J]. Cancer Epiderniol Biomarkers Prey, 2006, 15(9): 194-202.
  • 9Rathcke CN, Johanscn JS, Vcstergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance[J]. Inflamm Res, 2006, 55(2): 53-59.
  • 10Brix JM, H6Uefl F, Koppensteiner R, et al. YKL-40 in type 2 diabetic patients with different levels of albuminuria[j]. Eur J Clin Invest, 2011, 41(6): 589-596.

引证文献8

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部